SO
CSBR icon

STRS Ohio’s Champions Oncology CSBR Stock Holding History

STRS Ohio’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-31,500
Closed -$355K – 2268
2021
Q1 		$355K Sell
31,500
-1,300
-4% -$15.1K ﹤0.01% 1671
2020
Q4 		$353K Hold
32,800
– – ﹤0.01% 1607
2020
Q3 		$303K Buy
32,800
+30,900
+1,626% +$275K ﹤0.01% 1562
2020
Q2 		$18K Buy
+1,900
New +$16.2K ﹤0.01% 2051

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

STRS Ohio's CSBR Position: Q2 2021 in Review

STRS Ohio sold out of Champions Oncology (CSBR) in Q2 2021, closing a stake of 31,500 shares — an estimated $355K sold.

STRS Ohio first reported a position in CSBR in Q2 2020 and held it in 4 quarters. The position peaked at $355K in Q1 2021. 38 funds tracked by Wall St. Rank hold CSBR as of Q2 2021.

  • STRS Ohio reported no remaining Champions Oncology position as of Q2 2021 after selling out during the quarter.
  • STRS Ohio sold 31,500 Champions Oncology shares in Q2 2021, an estimated $355K.
  • STRS Ohio first reported a position in Champions Oncology in Q2 2020 and held it in 4 quarters.
  • STRS Ohio's Champions Oncology position peaked at $355K in Q1 2021.
  • 38 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2021.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.